UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000062612
Receipt number R000071676
Scientific Title Effect of music on pain and anxiety during central venous port placement: a prospective randomized controlled trial
Date of disclosure of the study information 2026/09/01
Last modified on 2026/09/24 15:41:24

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of music on pain and anxiety during central venous port placement: a randomized controlled trial

Acronym

MUSIC-PORT trial

Scientific Title

Effect of music on pain and anxiety during central venous port placement: a prospective randomized controlled trial

Scientific Title:Acronym

MUSIC-PORT trial

Region

Japan


Condition

Condition

Patients undergoing central venous port placement

Classification by specialty

Surgery in general Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Central venous port placement is frequently performed in patients requiring cancer treatment or long-term venous access. As the procedure is commonly performed under local anesthesia, patients may experience pain and anxiety during the procedure. In recent years, music therapy has attracted attention as a safe and cost-effective adjunctive intervention for reducing pain and anxiety, and its effectiveness has been reported during procedures such as vascular access for hemodialysis, lumbar puncture, and cystoscopy. This randomized controlled trial aims to evaluate the effects of music therapy on pain and anxiety in patients undergoing central venous port placement, compared with a control group exposed to white noise.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Between-group difference in pain during central venous port placement, assessed immediately after the procedure using the Visual Analog Scale (VAS).

Key secondary outcomes

Change in anxiety scores before and after central venous port placement, assessed using the State-Trait Anxiety Inventory (STAI).
Changes in vital signs (heart rate and blood pressure) during central venous port placement.
Patient satisfaction assessed immediately after central venous port placement using a questionnaire and Visual Analog Scale (VAS).


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -but assessor(s) are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

Participants will listen to music through headphones or earphones during central venous port placement. Music will be played continuously from the start to the end of the procedure.

Interventions/Control_2

Participants will listen to white noise through headphones or earphones during central venous port placement. White noise will be played continuously from the start to the end of the procedure.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients undergoing central venous port placement.
Male or female patients aged 18 years or older.
Patients with adequate hearing ability who are able to receive an explanation of the central venous port placement procedure and personally provide written informed consent for the procedure.
Patients who, after receiving sufficient information about the study, voluntarily provide written informed consent to participate in the study.

Key exclusion criteria

Patients undergoing central venous port placement under general anesthesia.
Patients who receive analgesics (e.g., acetaminophen, nonsteroidal anti-inflammatory drugs [NSAIDs], or opioid analgesics) on the day of central venous port placement.
Patients with a history of congenital insensitivity to pain or other conditions associated with insensitivity to pain.
Patients who are considered unsuitable for participation in the study by the principal investigator.

Target sample size

390


Research contact person

Name of lead principal investigator

1st name Tadaaki
Middle name
Last name Shimizu

Organization

Department of Surgery, Shinshu University School of Medicine

Division name

Division of Gastroenterological, Hepato-Biliary-Pancreatic, Transplantation and Pediatric Surgery

Zip code

390-0821

Address

3-1-1 Asahi, Matsumoto, Nagano 390-8621, Japan

TEL

0263-35-4600

Email

tadaaki@shinshu-u.ac.jp


Public contact

Name of contact person

1st name Tadaaki
Middle name
Last name Shimizu

Organization

Department of Surgery, Shinshu University School of Medicine

Division name

Division of Gastroenterological, Hepato-Biliary-Pancreatic, Transplantation and Pediatric Surgery

Zip code

390-8621

Address

3-1-1 Asahi, Matsumoto, Nagano 390-8621, Japan

TEL

0263-37-2654

Homepage URL


Email

surgery1@shinshu-u.ac.jp


Sponsor or person

Institute

Shinshu University

Institute

Department

Personal name



Funding Source

Organization

nothing

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Committee for Medical and Health Research, Shinshu University School of Medicine

Address

3-1-1 Asahi, Matsumoto, Nagano, Japan

Tel

0263-37-3099

Email

mdrinri@shinshu-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 09 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2026 Year 08 Month 19 Day

Date of IRB


Anticipated trial start date

2026 Year 10 Month 01 Day

Last follow-up date

2032 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 08 Month 19 Day

Last modified on

2026 Year 09 Month 24 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000071676